![Jean-Pierre Sommadossi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Pierre Sommadossi
Directeur Général chez
ATEA PHARMACEUTICALS, INC.
Fortune : 31 M $ au 31/05/2026
Profil
Le Dr Jean-Pierre Sommadossi est président du conseil d'administration de Kezar Life Sciences, Inc. et président-directeur général d'Atea Pharmaceuticals, Inc. et membre du conseil de la découverte de la Harvard Medical School, ainsi que directeur indépendant d'ABG Acquisition Corp. I. Il est membre du conseil d'administration de Rafael Pharmaceuticals, Inc. et de The BioExec Institute, Inc. et d'ABG Acquisition Corp. I. Le Dr Sommadossi était auparavant employé en tant que président-directeur général d'Idenix Pharmaceuticals LLC, cofondateur de Pharmasset, Inc. et professeur à l'Université d'Alabama à Birmingham, Fogarty Fellow au Medical College of Virginia, Fogarty Fellow au National Cancer Institute et conseiller chez Puretech Health LLC. Il a également siégé au conseil d'administration d'Alzheon, Inc. et de Kinex Pharmaceuticals, Inc. Il a obtenu son doctorat à l'université de Marseille.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2026 | 6 633 855 ( 8,29 % ) | 31 M $ | 31/05/2026 |
Postes actifs de Jean-Pierre Sommadossi
| Sociétés | Poste | Début |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Directeur Général | 01/12/2012 |
| ABG ACQUISITION CORP. I | Directeur/Membre du Conseil | 01/02/2021 |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Directeur/Membre du Conseil | 01/01/2004 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Président | 01/01/2015 |
Anciens postes connus de Jean-Pierre Sommadossi
| Sociétés | Poste | Fin |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Président | 11/05/2022 |
Pegaone GmbH
 Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Président | 01/01/2021 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2021 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Directeur/Membre du Conseil | 01/11/2020 |
| ATHENEXPAR | Directeur/Membre du Conseil | 01/07/2014 |
Formation de Jean-Pierre Sommadossi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
University of Marseille
 University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medical College of Virginia
 Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama at Birmingham
 The University of Alabama at Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Kezar Life Sciences, Inc.
 Kezar Life Sciences, Inc. BiotechnologyHealth Technology Discovers and develops therapies targeting protein homeostasis | Health Technology |
Pegaone GmbH
Pegaone GmbH Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals for allergic reactions & anaphylaxis | Health Technology |
ABG Acquisition Corp. I
 ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
